Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells
- PMID: 8142654
Downregulation of Wilms' tumor gene (wt1) during myelomonocytic differentiation in HL60 cells
Abstract
The putative Wilms' tumor-suppressor gene (wt1) encodes a zinc finger DNA binding protein that functions as a transcription repressor. The wt1 gene expression corresponds to kidney development, suggesting a role for this gene in nephroblast differentiation. Here we show that wt1 mRNA expression was downregulated during terminal differentiation of promyelocytic HL60 cells. When HL60 cells were induced to differentiate to granulocytes by dimethyl sulfoxide (DMSO) or retinoic acid (RA), a marked downregulation in the levels of wt1 transcripts was found. The wt1 transcripts were also downregulated in HL60 cells during differentiation to monocytes by vitamin D3 or 12-o-tetradecanoyl-phorbol-13-acetate. Nuclear run-on transcription studies showed the transcriptional rate of wt1 gene was not significantly altered during DMSO-induced granulocytic differentiation, suggesting the downregulation was mostly caused by posttranscriptional modification. Importantly, wt1 transcripts were not significantly altered in K562 cells by treatments with DMSO or RA, which do not induce differentiation of K562 cells. These findings suggest that wt1 gene expression may be downregulated as a differentiation-linked event in HL60 cells.
Similar articles
-
Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.Cell Growth Differ. 1997 Feb;8(2):133-43. Cell Growth Differ. 1997. PMID: 9040935
-
Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells.Cell Growth Differ. 1994 Jun;5(6):677-86. Cell Growth Differ. 1994. PMID: 8086342
-
Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program.Oncogene. 1998 Feb 19;16(7):925-32. doi: 10.1038/sj.onc.1201613. Oncogene. 1998. PMID: 9484784
-
The role of Wilms' tumor genes.J Med Invest. 1999 Aug;46(3-4):130-40. J Med Invest. 1999. PMID: 10687307 Review.
-
Wilms tumor and the WT1 gene.Exp Cell Res. 2001 Mar 10;264(1):74-99. doi: 10.1006/excr.2000.5131. Exp Cell Res. 2001. PMID: 11237525 Review.
Cited by
-
Mutation analysis of the WT1 gene in myelodysplastic syndromes.Jpn J Cancer Res. 1998 Aug;89(8):821-4. doi: 10.1111/j.1349-7006.1998.tb00634.x. Jpn J Cancer Res. 1998. PMID: 9765617 Free PMC article.
-
High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.Int J Hematol. 2012 Oct;96(4):469-76. doi: 10.1007/s12185-012-1163-1. Epub 2012 Aug 23. Int J Hematol. 2012. PMID: 22915059
-
Different kinetics of WT1 and PML-RARalpha gene expression levels during remission induction therapy with all-trans retinoic acid alone in acute promyelocytic leukemia.Int J Hematol. 2006 Dec;84(5):468-70. doi: 10.1532/IJH97.06161. Int J Hematol. 2006. PMID: 17189233 No abstract available.
-
Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.Jpn J Cancer Res. 1999 Feb;90(2):194-204. doi: 10.1111/j.1349-7006.1999.tb00733.x. Jpn J Cancer Res. 1999. PMID: 10189890 Free PMC article.
-
Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.Oncology. 2008;75(3-4):203-14. doi: 10.1159/000163849. Epub 2008 Oct 14. Oncology. 2008. PMID: 18852491 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
